Skip to main content

Advertisement

SpringerLink
Log in

Exercise in Hypertrophic Cardiomyopathy

  • Published:
Journal of Cardiovascular Translational Research Aims and scope Submit manuscript

Abstract

The risk of sudden cardiac death (SCD) associated with vigorous athletic competition in individuals with hypertrophic cardiomyopathy (HCM) is well documented, and is the basis for recommended exclusion from competitive sports independent of other risk factors. Although SCD risk with recreational exercise is less well defined, published guidelines for participation in recreational sports, based on a consensus of expert opinion, offer a valuable framework for counseling patients. Exercise stress testing is an important diagnostic and prognostic tool in the evaluation of HCM patients, providing an objective measure of functional capacity, physiologic hemodynamic responses to stress, presence of ischemia, and provocable left ventricular outflow tract obstruction. The value of cardiopulmonary exercise testing in HCM is less well studied than in the heart failure population, but can be used to set a safe target for exercise intensity as part of an individualized exercise prescription. The long-term effects of exercise on HCM pathophysiology are largely theoretical at this stage. Potential harmful effects of fatiguing exercise include prolonged contractile dysfunction resulting from microvascular ischemia and energetic compromise. Conversely, several animal studies have shown that voluntary exercise prevents or reverses many pathologic features of HCM, including those related to apoptosis and energetics. Substantial evidence for health-promoting benefits of exercise in the general population, in addition to promising safety and efficacy data in patients with chronic heart failure, emphasizes the need to attain a reasonable balance between potential risks and benefits of aerobic fitness in individuals with HCM.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Thompson, P. D., Franklin, B. A., Balady, G. J., Blair, S. N., Corrado, D., Estes, N. A., 3rd, et al. (2007). Exercise and acute cardiovascular events placing the risks into perspective: A scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism and the Council on Clinical Cardiology. Circulation, 115(17), 2358–2368.

    Article  PubMed  Google Scholar 

  2. Corrado, D., Basso, C., Rizzoli, G., Schiavon, M., & Thiene, G. (2003). Does sports activity enhance the risk of sudden death in adolescents and young adults? Journal of the American College of Cardiology, 42(11), 1959–1963.

    Article  PubMed  Google Scholar 

  3. Fletcher, G. F., Balady, G., Blair, S. N., Blumenthal, J., Caspersen, C., Chaitman, B., et al. (1996). Statement on exercise: Benefits and recommendations for physical activity programs for all Americans. A statement for health professionals by the Committee on Exercise and Cardiac Rehabilitation of the Council on Clinical Cardiology, American Heart Association. Circulation, 94(4), 857–862.

    CAS  PubMed  Google Scholar 

  4. Kokkinos, P., Myers, J., Kokkinos, J. P., Pittaras, A., Narayan, P., Manolis, A., et al. (2008). Exercise capacity and mortality in black and white men. Circulation, 117(5), 614–622.

    Article  PubMed  Google Scholar 

  5. Gulati, M., Black, H. R., Shaw, L. J., Arnsdorf, M. F., Merz, C. N., Lauer, M. S., et al. (2005). The prognostic value of a nomogram for exercise capacity in women. New England Journal of Medicine, 353(5), 468–475.

    Article  CAS  PubMed  Google Scholar 

  6. Maron, B. J. (2003). Sudden death in young athletes. New England Journal of Medicine, 349(11), 1064–1075.

    Article  CAS  PubMed  Google Scholar 

  7. Maron, B. J., Shirani, J., Poliac, L. C., Mathenge, R., Roberts, W. C., & Mueller, F. O. (1996). Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles. JAMA, 276(3), 199–204.

    Article  CAS  PubMed  Google Scholar 

  8. Maron, B. J., Doerer, J. J., Haas, T. S., Tierney, D. M., & Mueller, F. O. (2009). Sudden deaths in young competitive athletes: Analysis of 1866 deaths in the United States, 1980–2006. Circulation, 119(8), 1085–1092.

    Article  PubMed  Google Scholar 

  9. Rowland, T. (2007). Sudden cardiac death in athletes: Rethinking “hypertropic cardiomyopathy”. Pediatric Exercise Science, 19(4), 373–383.

    PubMed  Google Scholar 

  10. Maron, B. J., Ackerman, M. J., Nishimura, R. A., Pyeritz, R. E., Towbin, J. A., & Udelson, J. E. (2005). Task Force 4: HCM and other cardiomyopathies, mitral valve prolapse, myocarditis, and Marfan syndrome. Journal of the American College of Cardiology, 45(8), 1340–1345.

    Article  PubMed  Google Scholar 

  11. Pelliccia, A., Fagard, R., Bjornstad, H. H., Anastassakis, A., Arbustini, E., Assanelli, D., et al. (2005). Recommendations for competitive sports participation in athletes with cardiovascular disease: A consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. European Heart Journal, 26(14), 1422–1445.

    Article  PubMed  Google Scholar 

  12. Maron, B. J., Chaitman, B. R., Ackerman, M. J., Bayes de Luna, A., Corrado, D., Crosson, J. E., et al. (2004). Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases. Circulation, 109(22), 2807–2816.

    Article  PubMed  Google Scholar 

  13. Pelliccia, A., Corrado, D., Bjornstad, H. H., Panhuyzen-Goedkoop, N., Urhausen, A., Carre, F., et al. (2006). Recommendations for participation in competitive sport and leisure-time physical activity in individuals with cardiomyopathies, myocarditis and pericarditis. Eur J Cardiovasc Prev Rehabil, 13(6), 876–885.

    Article  PubMed  Google Scholar 

  14. Pelliccia, A., Zipes, D. P., & Maron, B. J. (2008). Bethesda Conference #36 and the European Society of Cardiology Consensus Recommendations revisited a comparison of U. S. and European criteria for eligibility and disqualification of competitive athletes with cardiovascular abnormalities. Journal of the American College of Cardiology, 52(24), 1990–1996.

    Article  PubMed  Google Scholar 

  15. Kim, J. B., Porreca, G. J., Song, L., Greenway, S. C., Gorham, J. M., Church, G. M., et al. (2007). Polony multiplex analysis of gene expression (PMAGE) in mouse hypertrophic cardiomyopathy. Science, 316(5830), 1481–1484.

    Article  CAS  PubMed  Google Scholar 

  16. Sadoul, N., Prasad, K., Elliott, P. M., Bannerjee, S., Frenneaux, M. P., & McKenna, W. J. (1997). Prospective prognostic assessment of blood pressure response during exercise in patients with hypertrophic cardiomyopathy. Circulation, 96(9), 2987–2991.

    CAS  PubMed  Google Scholar 

  17. Drinko, J. K., Nash, P. J., Lever, H. M., & Asher, C. R. (2004). Safety of stress testing in patients with hypertrophic cardiomyopathy. American Journal of Cardiology, 93(11), 1443–1444. A1412.

    Article  PubMed  Google Scholar 

  18. Bunch, T. J., Chandrasekaran, K., Ehrsam, J. E., Hammill, S. C., Urban, L. H., Hodge, D. O., et al. (2007). Prognostic significance of exercise induced arrhythmias and echocardiographic variables in hypertrophic cardiomyopathy. American Journal of Cardiology, 99(6), 835–838.

    Article  PubMed  Google Scholar 

  19. Maron, M. S., Olivotto, I., Zenovich, A. G., Link, M. S., Pandian, N. G., Kuvin, J. T., et al. (2006). Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction. Circulation, 114(21), 2232–2239.

    Article  PubMed  Google Scholar 

  20. Shah, J. S., Esteban, M. T., Thaman, R., Sharma, R., Mist, B., Pantazis, A., et al. (2008). Prevalence of exercise-induced left ventricular outflow tract obstruction in symptomatic patients with non-obstructive hypertrophic cardiomyopathy. Heart (British Cardiac Society), 94(10), 1288–1294.

    CAS  Google Scholar 

  21. Vaglio, J. C., Jr., Ommen, S. R., Nishimura, R. A., Tajik, A. J., & Gersh, B. J. (2008). Clinical characteristics and outcomes of patients with hypertrophic cardiomyopathy with latent obstruction. American Heart Journal, 156(2), 342–347.

    Article  PubMed  Google Scholar 

  22. Elliott, P. M., Poloniecki, J., Dickie, S., Sharma, S., Monserrat, L., Varnava, A., et al. (2000). Sudden death in hypertrophic cardiomyopathy: Identification of high risk patients. Journal of the American College of Cardiology, 36(7), 2212–2218.

    Article  CAS  PubMed  Google Scholar 

  23. Ciampi, Q., Betocchi, S., Losi, M. A., Ferro, A., Cuocolo, A., Lombardi, R., et al. (2007). Abnormal blood-pressure response to exercise and oxygen consumption in patients with hypertrophic cardiomyopathy. Journal of Nuclear Cardiology, 14(6), 869–875.

    Article  PubMed  Google Scholar 

  24. Kawasaki, T., Azuma, A., Kuribayashi, T., Akakabe, Y., Yamano, M., Miki, S., et al. (2008). Vagal enhancement due to subendocardial ischemia as a cause of abnormal blood pressure response in hypertrophic cardiomyopathy. International Journal of Cardiology, 129(1), 59–64.

    Article  PubMed  Google Scholar 

  25. Cecchi, F., Olivotto, I., Gistri, R., Lorenzoni, R., Chiriatti, G., & Camici, P. G. (2003). Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy. New England Journal of Medicine, 349(11), 1027–1035.

    Article  CAS  PubMed  Google Scholar 

  26. Petersen, S. E., Jerosch-Herold, M., Hudsmith, L. E., Robson, M. D., Francis, J. M., Doll, H. A., et al. (2007). Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: New insights from multiparametric magnetic resonance imaging. Circulation, 115(18), 2418–2425.

    Article  PubMed  Google Scholar 

  27. Jones, S., Elliott, P. M., Sharma, S., McKenna, W. J., & Whipp, B. J. (1998). Cardiopulmonary responses to exercise in patients with hypertrophic cardiomyopathy. Heart (British Cardiac Society), 80(1), 60–67.

    CAS  Google Scholar 

  28. Sharma, S., Elliott, P., Whyte, G., Jones, S., Mahon, N., Whipp, B., et al. (2000). Utility of cardiopulmonary exercise in the assessment of clinical determinants of functional capacity in hypertrophic cardiomyopathy. American Journal of Cardiology, 86(2), 162–168.

    Article  CAS  PubMed  Google Scholar 

  29. Lele, S. S., Thomson, H. L., Seo, H., Belenkie, I., McKenna, W. J., & Frenneaux, M. P. (1995). Exercise capacity in hypertrophic cardiomyopathy. Role of stroke volume limitation, heart rate, and diastolic filling characteristics. Circulation, 92(10), 2886–2894.

    CAS  PubMed  Google Scholar 

  30. Le, V. V., Perez, M. V., Wheeler, M. T., Myers, J., Schnittger, I., & Ashley, E. A. (2009). Mechanisms of exercise intolerance in patients with hypertrophic cardiomyopathy. American Heart Journal, 158(3), e27–e34.

    Article  PubMed  Google Scholar 

  31. Ingle, L. (2007). Theoretical rationale and practical recommendations for cardiopulmonary exercise testing in patients with chronic heart failure. Heart Failure Reviews, 12(1), 12–22.

    Article  PubMed  Google Scholar 

  32. Myers, J., Gullestad, L., Vagelos, R., Do, D., Bellin, D., Ross, H., et al. (1998). Clinical, hemodynamic, and cardiopulmonary exercise test determinants of survival in patients referred for evaluation of heart failure. Annals of Internal Medicine, 129(4), 286–293.

    CAS  PubMed  Google Scholar 

  33. Flynn, K. E., Pina, I. L., Whellan, D. J., Lin, L., Blumenthal, J. A., Ellis, S. J., et al. (2009). Effects of exercise training on health status in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA, 301(14), 1451–1459.

    Article  CAS  PubMed  Google Scholar 

  34. O’Connor, C. M., Whellan, D. J., Lee, K. L., Keteyian, S. J., Cooper, L. S., Ellis, S. J., et al. (2009). Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA, 301(14), 1439–1450.

    Article  PubMed  Google Scholar 

  35. Myers, J. (2008). Principles of exercise prescription for patients with chronic heart failure. Heart Failure Reviews, 13(1), 61–68.

    Article  PubMed  Google Scholar 

  36. Pelliccia, F., Cianfrocca, C., Pristipino, C., Pasceri, V., Auriti, A., Richichi, G., et al. (2007). Cumulative exercise-induced left ventricular systolic and diastolic dysfunction in hypertrophic cardiomyopathy. International Journal of Cardiology, 122(1), 76–78.

    Article  PubMed  Google Scholar 

  37. Sakata, K., Ino, H., Fujino, N., Nagata, M., Uchiyama, K., Hayashi, K., et al. (2008). Exercise-induced systolic dysfunction in patients with non-obstructive hypertrophic cardiomyopathy and mutations in the cardiac troponin genes. Heart (British Cardiac Society), 94(10), 1282–1287.

    CAS  Google Scholar 

  38. Ashrafian, H., & Watkins, H. (2008). Exercise-induced ventricular dysfunction in hypertrophic cardiomyopathy: Stunning by any other name? Heart (British Cardiac Society), 94(10), 1251–1253.

    Google Scholar 

  39. Nguyen, L., Chung, J., Lam, L., Tsoutsman, T., & Semsarian, C. (2007). Abnormal cardiac response to exercise in a murine model of familial hypertrophic cardiomyopathy. International Journal of Cardiology, 119(2), 245–248.

    Article  PubMed  Google Scholar 

  40. Geisterfer-Lowrance, A. A., Christe, M., Conner, D. A., Ingwall, J. S., Schoen, F. J., Seidman, C. E., et al. (1996). A mouse model of familial hypertrophic cardiomyopathy. Science, 272(5262), 731–734.

    Article  CAS  PubMed  Google Scholar 

  41. Siscovick, D. S., Weiss, N. S., Fletcher, R. H., & Lasky, T. (1984). The incidence of primary cardiac arrest during vigorous exercise. New England Journal of Medicine, 311(14), 874–877.

    Article  CAS  PubMed  Google Scholar 

  42. Konhilas, J. P., Watson, P. A., Maass, A., Boucek, D. M., Horn, T., Stauffer, B. L., et al. (2006). Exercise can prevent and reverse the severity of hypertrophic cardiomyopathy. Circulation Research, 98(4), 540–548.

    Article  CAS  PubMed  Google Scholar 

  43. Watson, P. A., Reusch, J. E., McCune, S. A., Leinwand, L. A., Luckey, S. W., Konhilas, J. P., et al. (2007). Restoration of CREB function is linked to completion and stabilization of adaptive cardiac hypertrophy in response to exercise. American Journal of Physiology. Heart and Circulatory Physiology, 293(1), H246–H259.

    Article  CAS  PubMed  Google Scholar 

  44. McMullen, J. R., Amirahmadi, F., Woodcock, E. A., Schinke-Braun, M., Bouwman, R. D., Hewitt, K. A., et al. (2007). Protective effects of exercise and phosphoinositide 3-kinase(p110alpha) signaling in dilated and hypertrophic cardiomyopathy. Proceedings of the National Academy of Sciences of the United States of America, 104(2), 612–617.

    Article  CAS  PubMed  Google Scholar 

  45. McKelvie, R. S. (2008). Exercise training in patients with heart failure: Clinical outcomes, safety, and indications. Heart Failure Reviews, 13(1), 3–11.

    Article  PubMed  Google Scholar 

  46. Piepoli, M. F., Davos, C., Francis, D. P., & Coats, A. J. (2004). Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH). BMJ, 328(7433), 189.

    Article  CAS  PubMed  Google Scholar 

  47. van Tol, B. A., Huijsmans, R. J., Kroon, D. W., Schothorst, M., & Kwakkel, G. (2006). Effects of exercise training on cardiac performance, exercise capacity and quality of life in patients with heart failure: A meta-analysis. European Journal of Heart Failure, 8(8), 841–850.

    Article  PubMed  Google Scholar 

  48. Frenneaux, M. P., Counihan, P. J., Caforio, A. L., Chikamori, T., & McKenna, W. J. (1990). Abnormal blood pressure response during exercise in hypertrophic cardiomyopathy. Circulation, 82(6), 1995–2002.

    CAS  PubMed  Google Scholar 

  49. Prasad, K., Williams, L., Campbell, R., Elliott, P. M., McKenna, W. J., & Frenneaux, M. (2008). Episodic syncope in hypertrophic cardiomyopathy: Evidence for inappropriate vasodilation. Heart (British Cardiac Society), 94(10), 1312–1317.

    CAS  Google Scholar 

  50. Thompson, P. D., Buchner, D., Pina, I. L., Balady, G. J., Williams, M. A., Marcus, B. H., et al. (2003). Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: A statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity). Circulation, 107(24), 3109–3116.

    Article  PubMed  Google Scholar 

  51. Mozaffarian, D., Wilson, P. W., & Kannel, W. B. (2008). Beyond established and novel risk factors: Lifestyle risk factors for cardiovascular disease. Circulation, 117(23), 3031–3038.

    Article  PubMed  Google Scholar 

  52. Djousse, L., Driver, J. A., & Gaziano, J. M. (2009). Relation between modifiable lifestyle factors and lifetime risk of heart failure. JAMA, 302(4), 394–400.

    Article  CAS  PubMed  Google Scholar 

  53. Maron, B. J., Thompson, P. D., Ackerman, M. J., Balady, G., Berger, S., Cohen, D., et al. (2007). Recommendations and considerations related to preparticipation screening for cardiovascular abnormalities in competitive athletes: 2007 update: A scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: Endorsed by the American College of Cardiology Foundation. Circulation, 115(12), 1643–1455.

    Article  PubMed  Google Scholar 

  54. Myers, J., Prakash, M., Froelicher, V., Do, D., Partington, S., & Atwood, J. E. (2002). Exercise capacity and mortality among men referred for exercise testing. New England Journal of Medicine, 346(11), 793–801.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Cardiovascular Medicine, University of Michigan Health System, 1150 W. Medical Center Dr, 7301 MSRB III, Ann Arbor, MI, 48109, USA

    Sharlene M. Day

Authors
  1. Sharlene M. Day
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sharlene M. Day.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Day, S.M. Exercise in Hypertrophic Cardiomyopathy. J. of Cardiovasc. Trans. Res. 2, 407–414 (2009). https://doi.org/10.1007/s12265-009-9134-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12265-009-9134-5

Keywords

Search

Navigation